Total Payments
$1,119
2024 Payments
$282.46
Companies
16
Transactions
57
Medicare Patients
10,788
Medicare Billing
$868,104
Payment Breakdown by Category
Food & Beverage$1,119 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,119 | 57 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $311.89 | 14 | $0 (2024) |
| GENZYME CORPORATION | $216.41 | 11 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $139.48 | 8 | $0 (2024) |
| PFIZER INC. | $81.57 | 5 | $0 (2023) |
| Janssen Biotech, Inc. | $76.02 | 4 | $0 (2022) |
| Kyowa Kirin, Inc. | $53.23 | 3 | $0 (2024) |
| Celgene Corporation | $44.80 | 1 | $0 (2019) |
| Organon Llc | $39.45 | 2 | $0 (2024) |
| Genentech USA, Inc. | $30.53 | 2 | $0 (2022) |
| Arcutis Biotherapeutics, Inc. | $23.59 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $282.46 | 13 | ABBVIE INC. ($93.95) |
| 2023 | $306.12 | 17 | AbbVie Inc. ($101.44) |
| 2022 | $337.92 | 17 | ABBVIE INC. ($78.36) |
| 2021 | $15.19 | 1 | Incyte Corporation ($15.19) |
| 2020 | $12.36 | 1 | PFIZER INC. ($12.36) |
| 2019 | $73.68 | 3 | Celgene Corporation ($44.80) |
| 2018 | $90.98 | 5 | Galderma Laboratories, L.P. ($23.43) |
All Payment Transactions
57 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/21/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $28.61 | General |
| Category: Immunology | ||||||
| 11/19/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $24.71 | General |
| Category: IMMUNOLOGY | ||||||
| 11/07/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $16.19 | General |
| Category: Immunology | ||||||
| 10/31/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $21.82 | General |
| Category: Immunology | ||||||
| 10/31/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $19.53 | General |
| Category: IMMUNOLOGY | ||||||
| 09/18/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $22.79 | General |
| Category: IMMUNOLOGY | ||||||
| 09/04/2024 | Organon Llc | HADLIMA (Drug) | Food and Beverage | In-kind items and services | $19.61 | General |
| Category: ADALIMUMAB-BWWD | ||||||
| 08/21/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $26.92 | General |
| Category: IMMUNOLOGY | ||||||
| 07/23/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $18.62 | General |
| Category: Immunology | ||||||
| 06/26/2024 | Organon Llc | HADLIMA (Drug) | Food and Beverage | In-kind items and services | $19.84 | General |
| Category: ADALIMUMAB-BWWD | ||||||
| 05/09/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $23.59 | General |
| Category: Dermatology | ||||||
| 02/27/2024 | Kyowa Kirin, Inc. | Poteligeo (Drug) | Food and Beverage | In-kind items and services | $19.46 | General |
| Category: Monoclonal Antibody | ||||||
| 02/21/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $20.77 | General |
| Category: Immunology | ||||||
| 12/14/2023 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $19.45 | General |
| Category: Immunology | ||||||
| 12/12/2023 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $14.67 | General |
| Category: Immunology | ||||||
| 12/05/2023 | AbbVie Inc. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $13.93 | General |
| Category: IMMUNOLOGY | ||||||
| 10/18/2023 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $14.41 | General |
| Category: Immunology | ||||||
| 10/03/2023 | GENZYME CORPORATION | DUPIXENT (Biological), DUPIXENT | Food and Beverage | In-kind items and services | $14.88 | General |
| Category: Immunology | ||||||
| 08/23/2023 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $17.95 | General |
| Category: Immunology | ||||||
| 08/10/2023 | AbbVie Inc. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $28.58 | General |
| Category: IMMUNOLOGY | ||||||
| 07/11/2023 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $15.72 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 06/14/2023 | AbbVie Inc. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $16.34 | General |
| Category: IMMUNOLOGY | ||||||
| 05/18/2023 | AbbVie Inc. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $15.52 | General |
| Category: IMMUNOLOGY | ||||||
| 04/24/2023 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $31.03 | General |
| Category: Immunology | ||||||
| 04/13/2023 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $15.52 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 28 | 2,549 | 4,029 | $482,753 | $197,171 |
| 2022 | 28 | 2,871 | 4,872 | $581,335 | $235,198 |
| 2021 | 25 | 2,689 | 4,423 | $509,210 | $216,780 |
| 2020 | 30 | 2,679 | 4,875 | $555,375 | $218,955 |
Total Patients
10,788
Total Services
18,199
Medicare Billing
$868,104
Procedure Codes
111
All Medicare Procedures & Services
111 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Office | 2023 | 845 | 1,428 | $214,200 | $74,317 | 34.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 438 | 522 | $49,590 | $29,176 | 58.8% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 176 | 194 | $29,100 | $12,348 | 42.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 92 | 108 | $14,580 | $9,184 | 63.0% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 207 | 244 | $24,400 | $9,050 | 37.1% |
| 88312 | Special stained specimen slides to identify organisms including interpretation and report | Office | 2023 | 62 | 96 | $17,145 | $8,005 | 46.7% |
| 12032 | Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | Office | 2023 | 36 | 39 | $18,525 | $7,483 | 40.4% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 64 | 69 | $10,005 | $4,710 | 47.1% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 66 | 104 | $7,280 | $3,903 | 53.6% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 55 | 55 | $7,700 | $3,770 | 49.0% |
| 13121 | Complicated repair of wound of scalp, arms, or legs, 2.6-7.5 cm | Office | 2023 | 12 | 12 | $8,040 | $3,620 | 45.0% |
| 17262 | Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | Office | 2023 | 28 | 30 | $6,878 | $3,421 | 49.7% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 151 | 699 | $10,485 | $3,378 | 32.2% |
| 12031 | Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.5 cm or less | Office | 2023 | 18 | 18 | $5,850 | $3,182 | 54.4% |
| 12042 | Intermediate repair of wound of neck, hands, feet, or genitals, 2.6-7.5 cm | Office | 2023 | 11 | 11 | $5,335 | $2,387 | 44.8% |
| 11602 | Removal of cancer skin growth of body, arms, or legs, 1.1-2.0 cm | Office | 2023 | 22 | 25 | $9,375 | $2,355 | 25.1% |
| 88341 | Special stained specimen slides to examine tissue, each additional procedure | Office | 2023 | 18 | 102 | $5,100 | $2,215 | 43.4% |
| 11603 | Removal of cancer skin growth of body, arms, or legs, 2.1-3.0 cm | Office | 2023 | 18 | 19 | $8,550 | $2,049 | 24.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 17 | 17 | $3,400 | $1,664 | 48.9% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2023 | 14 | 14 | $2,940 | $1,645 | 56.0% |
| 11104 | Punch biopsy, first skin growth | Office | 2023 | 18 | 19 | $3,325 | $1,631 | 49.1% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 38 | 41 | $2,460 | $1,588 | 64.6% |
| 88304 | Pathology examination of tissue using a microscope, moderately low complexity | Office | 2023 | 38 | 52 | $4,680 | $1,558 | 33.3% |
| 11622 | Removal of cancer skin growth of scalp, neck, hands, feet, or genitals, 1.1-2.0 cm | Office | 2023 | 11 | 11 | $4,620 | $1,071 | 23.2% |
| 88344 | Special stained specimen slides to examine tissue, each multiplex procedure | Office | 2023 | 31 | 31 | $1,860 | $911.71 | 49.0% |
About Dr. Daniel Dapprich, M.D
Dr. Daniel Dapprich, M.D is a Dermatopathology healthcare provider based in Grand Rapids, Michigan. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/15/2005. The National Provider Identifier (NPI) number assigned to this provider is 1578549242.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Daniel Dapprich, M.D has received a total of $1,119 in payments from pharmaceutical and medical device companies, with $282.46 received in 2024. These payments were reported across 57 transactions from 16 companies. The most common payment nature is "Food and Beverage" ($1,119).
As a Medicare-enrolled provider, Dapprich has provided services to 10,788 Medicare beneficiaries, totaling 18,199 services with total Medicare billing of $868,104. Data is available for 4 years (2020–2023), covering 111 distinct procedure/service records.
Ad
Practice Information
- Specialty Dermatopathology
- Location Grand Rapids, MI
- Active Since 12/15/2005
- Last Updated 04/14/2022
- Taxonomy Code 207ND0900X
- Entity Type Individual
- NPI Number 1578549242
Products in Payments
- DUPIXENT (Biological) $221.24
- SKYRIZI (Biological) $208.83
- Sotyktu (Drug) $139.48
- EUCRISA (Drug) $64.68
- Otezla (Drug) $44.80
- TREMFYA (Drug) $44.48
- HADLIMA (Drug) $39.45
- RINVOQ (Biological) $35.87
- POTELIGEO (Drug) $33.77
- REMICADE (Biological) $31.54
- Erivedge (Biological) $30.53
- HUMIRA (Biological) $29.05
- Zoryve (Drug) $23.59
- SOOLANTRA (Drug) $23.43
- Sernivo Spray (Drug) $20.99
- Humira (Biological) $20.15
- Poteligeo (Drug) $19.46
- Skyrizi (Biological) $17.99
- CIBINQO (Drug) $16.89
- OPZELURA (Drug) $15.19
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.